Physician

Helen Jia-Ru Kuo, MD

According to 2025 Medicare claims, Helen Kuo, MD (NPI: 1346407921) practices urology in the Boise City, ID market, with the plurality of this provider's patient population coming from Ada, ID. This provider's primary affiliated billing organization is IDAHO UROLOGIC INSTITUTE PA (NPI: 1689620692; TIN: 20-1300128) and primary practice location at 83642-6245. Kuo is affiliated with the Trinity Health Integrated Care (ACO ID: A3454), participating under the MSSP model.

Kuo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 529 traditional Medicare patients, billed 10,023 HCPCS/CPT codes, and received $195,436 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,438 prescription claims across 437 beneficiaries totaling $241,787 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 31 claims. Open Payments data shows 41 records totaling $887. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $141,351 to $195,436. Similarly, Part D prescription costs have risen steadily, from $95,900 to $241,787. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $1,203 and ending at $701.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	338	7,201	$141,351
2016	382	8,237	$122,563
2017	441	5,373	$163,741
2018	464	6,723	$182,222
2019	466	6,638	$275,026
2020	471	6,897	$149,731
2021	481	9,187	$233,372
2022	559	11,098	$309,724
2023	513	8,657	$189,713
2024	529	10,023	$195,436

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	244	1,071	$95,900
2016	250	1,098	$110,919
2017	272	1,212	$130,185
2018	297	1,175	$151,099
2019	319	1,207	$153,109
2020	345	1,293	$191,275
2021	334	1,102	$127,201
2022	400	1,333	$157,722
2023	389	1,299	$191,555
2024	437	1,438	$241,787

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	143	$4,491
2016	N/R	110	$5,217
2017	N/R	72	$5,317
2018	N/R	113	$7,866
2019	N/R	85	$6,090
2020	N/R	49	$10,222
2021	N/R	30	$6,565
2022	N/R	96	$11,997
2023	N/R	137	$21,878
2024	N/R	31	$10,807

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	118	118	$112
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	137	184	$89
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	187	219	$59
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	166	207	$12
81001	Manual urinalysis test with examination using microscope, automated	300	420	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	245	11,639	$171,890
Gemtesa	Vibegron	34	1,760	$27,770
Methenamine Hippurate	Methenamine Hippurate	142	7,412	$9,418
Potassium Citrate Er	Potassium Citrate	34	2,665	$5,943
Trospium Chloride	Trospium Chloride	52	2,430	$5,268

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	31	$10,807

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	39	$887	Sumitomo Pharma America, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	2	$107,777	SN Holdings, LLC

Explore More Providers

FAQ

What Medicare data is available for Helen Jia-Ru Kuo, MD?

Tedicare shows public-source Medicare data for Helen Jia-Ru Kuo, MD (NPI 1346407921), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Helen Jia-Ru Kuo, MD have ACO affiliation data?

Helen Jia-Ru Kuo, MD is shown with ACO affiliation data for Trinity Health Integrated Care (MSSP, ACO ID A3454).

What billing organization is linked to Helen Jia-Ru Kuo, MD?

Helen Jia-Ru Kuo, MD is linked to IDAHO UROLOGIC INSTITUTE PA (billing NPI 1689620692) in the available physician profile data.

Does Helen Jia-Ru Kuo, MD have Open Payments data?

Helen Jia-Ru Kuo, MD has 41 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.